Hemeteam has six parts.

1: Hematopoiesis and related topics
2: Disease of hematopoiesis
3: Molecularly targeted therapy
4: Bleeding and clotting
5: Approach to common problems
6: Case studies

Hemeteam is free of charge and advertising, and the author has no conflicts of interest.

You may freely use The QxMD Hematology calculator which has many interesting applications.

Helping you find the best websites for study and research

by Peter R. Galbraith MD, FRCP(C) Last edited Apr 10, 2012

Welcome to HemeTeam 2012

HemeTeam is a companion to hematological studies. These notes on the pathogenesis, manifestations and treatment of common blood diseases, are frequently updated to reflect advances in research.

The most important recent advance in malignant hematology is the recognition of the prime importance of the supportive tumour cell microenvironment such as in multiple myeloma, and the need to target it in refractory cases of chronic lymphocytic leukemia. The microenvironment has been relatively neglected in diseases such as peripheral T-cell lymphoma which are associated with a poor prognosis.

There are some case studies with MCQs and feedback.

To Navigate: Use the links on this page.

Your browser's back (or forward) arrow bring you back to this page. The EXIT button exits HemeTeam.

Contents

Part 1. Hematopoiesis and related topics

Part 2. Diseases of Hematopoiesis:

a) Anemia and some cases

b) Stem cells

c) Lymphocytes

Part 3. Molecularly Targeted Therapy

Part 4. Bleeding and Clotting

Part 5. Approach to common problems

Part 6. Case studies again repeated here for convenience

You may freely use The QxMD Hematology Calculator which has many interesting uses.